FIELD: biotechnology.
SUBSTANCE: described are methods of treating Alzheimer's disease (AD) in the patients suffering from mild to moderate AD, including in patients with positive ApoE4 status, and patients suffering from mild AD. Methods of selecting patients for Abeta antibody therapy are also provided. Methods involve use of prognostic and/or predictive biomarkers.
EFFECT: there are presented methods of treating Alzheimer's disease.
68 cl, 18 dwg, 1 tbl, 3 ex
Authors
Dates
2020-04-30—Published
2015-02-06—Filed